To the Editor: Dr Kociol and colleagues1 conducted a retrospective analysis of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. The finding that patients in the United States with ST-elevation myocardial infarction (STEMI) are readmitted more frequently in the short-term compared with their international counterparts is concerning. Three points merit discussion. First, their analysis shows that shorter length of stay is related to more readmissions. The implication is that US patients are being treated suboptimally because they are rushed home by insurers. However, the authors noted that an association between length of stay and readmission has never been proven. In addition, prolonged length of stay would not be useful in uncomplicated, stable patients with STEMI.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.